United States Hirudin Market Report & Forecast 2021-2027

Publisher Name :
Date: 16-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Hirudin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Hirudin Market Segment Percentages, By Type, 2020 (%)

- Natural Hirudin

- Recombinant Hirudin

United States Hirudin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Hirudin Market Segment Percentages, By Application, 2020 (%)

- Thrombosis Disease

- Tumor Disease

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hirudin revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Hirudin revenues share in United States market, 2020 (%)

Key companies Hirudin sales in United States market, 2016-2021 (Estimated), (MT)

Key companies Hirudin sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- The Medicines Company

- Keyken

- Minapharm

- Abbott

- SALUBRIS

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- DUOPUTAI

- Pentapharm

United States Hirudin Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hirudin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Hirudin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Hirudin Overall Market Size
2.1 United States Hirudin Market Size: 2021 VS 2027
2.2 United States Hirudin Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Hirudin Sales: 2016-2027
3 Company Landscape
3.1 Top Hirudin Players in United States Market
3.2 Top United States Hirudin Companies Ranked by Revenue
3.3 United States Hirudin Revenue by Companies
3.4 United States Hirudin Sales by Companies
3.5 United States Hirudin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hirudin Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Hirudin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hirudin Players in United States Market
3.8.1 List of Tier 1 Hirudin Companies in United States
3.8.2 List of Tier 2 and Tier 3 Hirudin Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Hirudin Market Size Markets, 2021 & 2027
4.1.2 Natural Hirudin
4.1.3 Recombinant Hirudin
4.2 By Type - United States Hirudin Revenue & Forecasts
4.2.1 By Type - United States Hirudin Revenue, 2016-2021
4.2.2 By Type - United States Hirudin Revenue, 2022-2027
4.2.3 By Type - United States Hirudin Revenue Market Share, 2016-2027
4.3 By Type - United States Hirudin Sales & Forecasts
4.3.1 By Type - United States Hirudin Sales, 2016-2021
4.3.2 By Type - United States Hirudin Sales, 2022-2027
4.3.3 By Type - United States Hirudin Sales Market Share, 2016-2027
4.4 By Type - United States Hirudin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Hirudin Market Size, 2021 & 2027
5.1.2 Thrombosis Disease
5.1.3 Tumor Disease
5.1.4 Others
5.2 By Application - United States Hirudin Revenue & Forecasts
5.2.1 By Application - United States Hirudin Revenue, 2016-2021
5.2.2 By Application - United States Hirudin Revenue, 2022-2027
5.2.3 By Application - United States Hirudin Revenue Market Share, 2016-2027
5.3 By Application - United States Hirudin Sales & Forecasts
5.3.1 By Application - United States Hirudin Sales, 2016-2021
5.3.2 By Application - United States Hirudin Sales, 2022-2027
5.3.3 By Application - United States Hirudin Sales Market Share, 2016-2027
5.4 By Application - United States Hirudin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 The Medicines Company
6.1.1 The Medicines Company Corporation Information
6.1.2 The Medicines Company Overview
6.1.3 The Medicines Company Hirudin Sales and Revenue in United States Market (2016-2021)
6.1.4 The Medicines Company Hirudin Product Description
6.1.5 The Medicines Company Recent Developments
6.2 Keyken
6.2.1 Keyken Corporation Information
6.2.2 Keyken Overview
6.2.3 Keyken Hirudin Sales and Revenue in United States Market (2016-2021)
6.2.4 Keyken Hirudin Product Description
6.2.5 Keyken Recent Developments
6.3 Minapharm
6.3.1 Minapharm Corporation Information
6.3.2 Minapharm Overview
6.3.3 Minapharm Hirudin Sales and Revenue in United States Market (2016-2021)
6.3.4 Minapharm Hirudin Product Description
6.3.5 Minapharm Recent Developments
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Overview
6.4.3 Abbott Hirudin Sales and Revenue in United States Market (2016-2021)
6.4.4 Abbott Hirudin Product Description
6.4.5 Abbott Recent Developments
6.5 SALUBRIS
6.5.1 SALUBRIS Corporation Information
6.5.2 SALUBRIS Overview
6.5.3 SALUBRIS Hirudin Sales and Revenue in United States Market (2016-2021)
6.5.4 SALUBRIS Hirudin Product Description
6.5.5 SALUBRIS Recent Developments
6.6 Pfizer, Inc
6.6.1 Pfizer, Inc Corporation Information
6.6.2 Pfizer, Inc Overview
6.6.3 Pfizer, Inc Hirudin Sales and Revenue in United States Market (2016-2021)
6.6.4 Pfizer, Inc Hirudin Product Description
6.6.5 Pfizer, Inc Recent Developments
6.7 Teva Pharmaceutical Industries Ltd
6.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.7.2 Teva Pharmaceutical Industries Ltd Overview
6.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales and Revenue in United States Market (2016-2021)
6.7.4 Teva Pharmaceutical Industries Ltd Hirudin Product Description
6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
6.8 DUOPUTAI
6.8.1 DUOPUTAI Corporation Information
6.8.2 DUOPUTAI Overview
6.8.3 DUOPUTAI Hirudin Sales and Revenue in United States Market (2016-2021)
6.8.4 DUOPUTAI Hirudin Product Description
6.8.5 DUOPUTAI Recent Developments
6.9 Pentapharm
6.9.1 Pentapharm Corporation Information
6.9.2 Pentapharm Overview
6.9.3 Pentapharm Hirudin Sales and Revenue in United States Market (2016-2021)
6.9.4 Pentapharm Hirudin Product Description
6.9.5 Pentapharm Recent Developments
7 United States Hirudin Production Capacity, Analysis
7.1 United States Hirudin Production Capacity, 2016-2027
7.2 Hirudin Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hirudin Supply Chain Analysis
9.1 Hirudin Industry Value Chain
9.2 Hirudin Upstream Market
9.3 Hirudin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hirudin Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Hirudin in United States Market
Table 2. Top Hirudin Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Hirudin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Hirudin Revenue Share by Companies, 2016-2021
Table 5. United States Hirudin Sales by Companies, (MT), 2016-2021
Table 6. United States Hirudin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hirudin Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers Hirudin Product Type
Table 9. List of Tier 1 Hirudin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hirudin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Natural Hirudin
Table 12. Major Manufacturers of Recombinant Hirudin
Table 13. By Type - United States Hirudin Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Hirudin Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Hirudin Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Hirudin Sales (MT), 2016-2021
Table 17. By Type - United States Hirudin Sales (MT), 2022-2027
Table 18. By Application - United States Hirudin Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Hirudin Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Hirudin Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Hirudin Sales (MT), 2016-2021
Table 22. By Application - United States Hirudin Sales (MT), 2022-2027
Table 23. The Medicines Company Corporation Information
Table 24. The Medicines Company Description and Major Businesses
Table 25. The Medicines Company Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. The Medicines Company Hirudin Product
Table 27. The Medicines Company Recent Developments
Table 28. Keyken Corporation Information
Table 29. Keyken Description and Major Businesses
Table 30. Keyken Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. Keyken Hirudin Product
Table 32. Keyken Recent Developments
Table 33. Minapharm Corporation Information
Table 34. Minapharm Description and Major Businesses
Table 35. Minapharm Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Minapharm Hirudin Product
Table 37. Minapharm Recent Developments
Table 38. Abbott Corporation Information
Table 39. Abbott Description and Major Businesses
Table 40. Abbott Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. Abbott Hirudin Product
Table 42. Abbott Recent Developments
Table 43. SALUBRIS Corporation Information
Table 44. SALUBRIS Description and Major Businesses
Table 45. SALUBRIS Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. SALUBRIS Hirudin Product
Table 47. SALUBRIS Recent Developments
Table 48. Pfizer, Inc Corporation Information
Table 49. Pfizer, Inc Description and Major Businesses
Table 50. Pfizer, Inc Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. Pfizer, Inc Hirudin Product
Table 52. Pfizer, Inc Recent Developments
Table 53. Teva Pharmaceutical Industries Ltd Corporation Information
Table 54. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 55. Teva Pharmaceutical Industries Ltd Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. Teva Pharmaceutical Industries Ltd Hirudin Product
Table 57. Teva Pharmaceutical Industries Ltd Recent Developments
Table 58. DUOPUTAI Corporation Information
Table 59. DUOPUTAI Description and Major Businesses
Table 60. DUOPUTAI Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 61. DUOPUTAI Hirudin Product
Table 62. DUOPUTAI Recent Developments
Table 63. Pentapharm Corporation Information
Table 64. Pentapharm Description and Major Businesses
Table 65. Pentapharm Hirudin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 66. Pentapharm Hirudin Product
Table 67. Pentapharm Recent Developments
Table 68. Hirudin Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 69. United States Hirudin Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Hirudin Market Opportunities & Trends in United States Market
Table 71. Hirudin Market Drivers in United States Market
Table 72. Hirudin Market Restraints in United States Market
Table 73. Hirudin Raw Materials
Table 74. Hirudin Raw Materials Suppliers in United States Market
Table 75. Typical Hirudin Downstream
Table 76. Hirudin Downstream Clients in United States Market
Table 77. Hirudin Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Hirudin Segment by Type
Figure 3. Hirudin Segment by Application
Figure 4. United States Hirudin Market Overview: 2020
Figure 5. United States Hirudin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Hirudin Revenue, 2016-2027 (US$, Mn)
Figure 7. Hirudin Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Hirudin Revenue in 2020
Figure 9. Natural Hirudin Product Picture
Figure 10. Recombinant Hirudin Product Picture
Figure 11. By Type - United States Hirudin Sales Market Share, 2016-2027
Figure 12. By Type - United States Hirudin Revenue Market Share, 2016-2027
Figure 13. By Type - United States Hirudin Price (USD/Kg), 2016-2027
Figure 14. Thrombosis Disease
Figure 15. Tumor Disease
Figure 16. Others
Figure 17. By Application - United States Hirudin Sales Market Share, 2016-2027
Figure 18. By Application - United States Hirudin Revenue Market Share, 2016-2027
Figure 19. By Application - United States Hirudin Price (USD/Kg), 2016-2027
Figure 20. The Medicines Company Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Keyken Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Minapharm Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Abbott Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. SALUBRIS Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Pfizer, Inc Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Teva Pharmaceutical Industries Ltd Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. DUOPUTAI Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Pentapharm Hirudin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Hirudin Production Capacity (MT), 2016-2027
Figure 30. Hirudin Industry Value Chain
Figure 31. Marketing Channels
  • Global Peptic Ulcer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 20-Oct-2021        Price: US 3480 Onwards        Pages: 98
    The Peptic Ulcer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • China Capecitabine Fumarate Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Capecitabine Fumarate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Capecitabine Fumarate Market Segment Percentages, By Type, 2020 (%) - Capecitabine Fumarate Oral - Capecitabine Fumarate Infusion China Capecitabine Fumarate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Capecitabine Fumarate Market Segment Percentages, By Application, 2020 (%) - Breast Cancer - Rectal Cancer - ......
  • China Caffeine Citrate Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Caffeine Citrate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Caffeine Citrate Market Segment Percentages, By Type, 2020 (%) - Injection - Oral Solution - Tablet China Caffeine Citrate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Caffeine Citrate Market Segment Percentages, By Application, 2020 (%) - Pharmaceuticals - Others Competitor Analysis The report a......
  • China Axitinib Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Axitinib Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Axitinib Market Segment Percentages, By Type, 2020 (%) - Injection - Others China Axitinib Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Axitinib Market Segment Percentages, By Application, 2020 (%) - Renal Cancer Treatment - Others Competitor Analysis The report also provides analysis of leading market partic......
  • Global Indocyanine Green (CAS 3599-32-4) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 19-Oct-2021        Price: US 3480 Onwards        Pages: 86
    The Indocyanine Green (CAS 3599-32-4) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to ......
  • China Atracurium Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Atracurium Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Atracurium Market Segment Percentages, By Type, 2020 (%) - 25mg - 50mg China Atracurium Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Atracurium Market Segment Percentages, By Application, 2020 (%) - Hospital - Clinic - ASCs - Others Competitor Analysis The report also provides analysis of lead......
  • China Analgesics Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 91
    China Analgesics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Analgesics Market Segment Percentages, By Type, 2020 (%) - Non-Steroidal Anti-Inflammatory Drug - Central Pain Killers China Analgesics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Analgesics Market Segment Percentages, By Application, 2020 (%) - Hospital - Pharmacy - Family Competitor Analysis T......
  • Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2027
    Published: 18-Oct-2021        Price: US 3900 Onwards        Pages: 144
    Pneumonia Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Pneumonia Vaccine mar......
  • Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2027
    Published: 18-Oct-2021        Price: US 3900 Onwards        Pages: 139
    Organ Transplant Immunosuppressant Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs